| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.943 | 0.001 | 0.943 | Progesterone antagonist | 0.882 0.001 CID_13911053 | ||
| 0.816 | 0.012 | 0.816 | Transcription factor NF kappa B inhibitor | 0.805 0.012 CID_13911053 | ||
| 0.723 | 0.001 | 0.723 | Lipocortins synthesis antagonist | 0.682 0.001 CID_13911053 | ||
| 0.71 | 0.029 | 0.73 | Antiinflammatory | 0.73 0.025 CID_13911053 | CID_13911053 | |
| 0.661 | 0.003 | 0.661 | Androgen antagonist | 0.623 0.003 CID_13911053 | ||
| 0.654 | 0.003 | 0.654 | Estrogen receptor alpha antagonist | 0.445 0.004 CID_13911053 | ||
| 0.619 | 0.002 | 0.619 | Glucocorticoid antagonist | 0.549 0.002 CID_13911053 | ||
| 0.597 | 0.004 | 0.597 | Estrogen antagonist | 0.541 0.004 CID_13911053 | ||
| 0.55 | 0.003 | 0.55 | Estrogen agonist | 0.507 0.004 CID_13911053 | ||
| 0.594 | 0.05 | 0.594 | Apoptosis agonist | 0.548 0.061 CID_13911053 | ||
| 0.506 | 0.002 | 0.506 | Androgen agonist | 0.431 0.002 CID_13911053 | ||
| 0.498 | 0.004 | 0.498 | Sodium/bile acid cotransporter inhibitor | 0.483 0.005 CID_13911053 | ||
| 0.479 | 0.017 | 0.479 | Hypoxia-inducible factor 1 alpha inhibitor | 0.313 0.06 CID_13911053 | ||
| 0.443 | 0.003 | 0.443 | Estrogen receptor alpha agonist | 0.403 0.003 CID_13911053 | ||
| 0.424 | 0.023 | 0.424 | DNA damaging | 0.383 0.032 CID_13911053 | ||
| 0.435 | 0.051 | 0.435 | Immunosuppressant | 0.432 0.052 CID_13911053 | ||
| 0.422 | 0.045 | 0.422 | Cholesterol antagonist | 0.241 0.132 CID_13911053 | ||
| 0.365 | 0.003 | 0.365 | Mineralocorticoid receptor antagonist | 0.344 0.004 CID_13911053 | ||
| 0.364 | 0.003 | 0.364 | Estrogen receptor beta agonist | 0.326 0.004 CID_13911053 | ||
| 0.363 | 0.012 | 0.363 | Lipid peroxidase inhibitor | 0.359 0.012 CID_13911053 | ||
| 0.347 | 0.005 | 0.347 | Estrogen receptor beta antagonist | 0.302 0.005 CID_13911053 | ||
| 0.368 | 0.029 | 0.368 | Nitric oxide antagonist | 0.34 0.033 CID_13911053 | ||
| 0.366 | 0.054 | 0.366 | Caspase 3 stimulant | 0.323 0.069 CID_13911053 | ||
| 0.304 | 0.028 | 0.304 | P-glycoprotein inhibitor | 0.23 0.048 CID_13911053 | ||
| 0.296 | 0.034 | 0.296 | Anesthetic general | 0.254 0.049 CID_13911053 | ||
| 0.282 | 0.021 | 0.33 | NOS3 expression enhancer | 0.33 0.014 CID_13911053 | CID_13911053 | |
| 0.254 | 0.002 | 0.254 | Progesterone agonist | 0.213 0.002 CID_13911053 | ||
| 0.249 | 0.005 | 0.249 | Arachidonic acid antagonist | 0.232 0.011 CID_13911053 | ||
| 0.296 | 0.067 | 0.296 | Aldehyde oxidase inhibitor | 0.235 0.088 CID_13911053 | ||
| 0.207 | 0.004 | 0.207 | Estradiol 17 beta-dehydrogenase inhibitor | 0.076 0.014 CID_13911053 | ||
| 0.243 | 0.045 | 0.243 | Hepatoprotectant | 0.227 0.051 CID_13911053 | ||
| 0.197 | 0.004 | 0.197 | Anabolic | 0.194 0.005 CID_13911053 | ||
| 0.223 | 0.034 | 0.223 | Interferon gamma antagonist | 0.177 0.052 CID_13911053 | ||
| 0.217 | 0.038 | 0.217 | Antipruritic | 0.204 0.046 CID_13911053 | ||
| 0.178 | 0.006 | 0.178 | 5-Alpha-reductase inhibitor | 0.114 0.009 CID_13911053 | ||
| 0.25 | 0.083 | 0.25 | Antioxidant | 0.224 0.099 CID_13911053 | ||
| 0.185 | 0.031 | 0.185 | Alkylator | 0.158 0.043 CID_13911053 | ||
| 0.153 | 0.013 | 0.153 | Aromatase inhibitor | 0.111 0.019 CID_13911053 | ||
| 0.21 | 0.089 | 0.21 | Angiogenesis stimulant | 0.205 0.092 CID_13911053 | ||
| 0.288 | 0.174 | 0.288 | Cyclophilin D inhibitor | |||
| 0.159 | 0.052 | 0.165 | Bone formation stimulant | 0.165 0.049 CID_13911053 | CID_13911053 | |
| 0.108 | 0.004 | 0.108 | Lipocortins synthesis agonist | 0.104 0.004 CID_13911053 | ||
| 0.108 | 0.006 | 0.108 | RNA-directed RNA polymerase stimulant | 0.1 0.006 CID_13911053 | ||
| 0.097 | 0.005 | 0.097 | Estrone sulfatase inhibitor | 0.082 0.005 CID_13911053 | ||
| 0.145 | 0.059 | 0.145 | Farnesoid X receptor antagonist | 0.13 0.083 CID_13911053 | ||
| 0.289 | 0.206 | 0.295 | Caspase 9 stimulant | 0.295 0.199 CID_13911053 | CID_13911053 | |
| 0.117 | 0.039 | 0.117 | Antineoplastic alkaloid | 0.092 0.053 CID_13911053 | ||
| 0.148 | 0.07 | 0.148 | Protein kinase stimulant | 0.114 0.099 CID_13911053 | ||
| 0.14 | 0.063 | 0.14 | Tubulin antagonist | 0.136 0.066 CID_13911053 | ||
| 0.117 | 0.039 | 0.117 | Antineoplastic antibiotic | 0.111 0.041 CID_13911053 | ||
| 0.086 | 0.01 | 0.086 | Aldosterone antagonist | 0.085 0.01 CID_13911053 | ||
| 0.223 | 0.153 | 0.223 | Apoptosis antagonist | 0.221 0.155 CID_13911053 | ||
| 0.097 | 0.034 | 0.097 | Na+ K+ transporting ATPase inhibitor | 0.086 0.045 CID_13911053 | ||
| 0.069 | 0.006 | 0.069 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.088 | 0.026 | 0.088 | Beta tubulin antagonist | 0.084 0.028 CID_13911053 | ||
| 0.064 | 0.003 | 0.064 | Progesterone receptor B antagonist | 0.056 0.003 CID_13911053 | ||
| 0.067 | 0.006 | 0.067 | 5-Alpha-reductase 1 inhibitor | 0.024 0.01 CID_13911053 | ||
| 0.122 | 0.063 | 0.122 | Cholesterol synthesis inhibitor | |||
| 0.089 | 0.033 | 0.089 | Leukotriene synthesis inhibitor | 0.081 0.037 CID_13911053 | ||
| 0.14 | 0.085 | 0.14 | Diuretic | 0.13 0.095 CID_13911053 | ||
| 0.057 | 0.004 | 0.057 | Glucocorticoid agonist | 0.056 0.004 CID_13911053 | ||
| 0.146 | 0.095 | 0.182 | Interleukin 6 antagonist | 0.182 0.053 CID_13911053 | CID_13911053 | |
| 0.072 | 0.023 | 0.073 | Alpha tubulin antagonist | 0.073 0.023 CID_13911053 | CID_13911053 | |
| 0.07 | 0.025 | 0.07 | Heme oxygenase stimulant | 0.068 0.028 CID_13911053 | ||
| 0.046 | 0.003 | 0.046 | Corticosteroid-like | 0.043 0.004 CID_13911053 | ||
| 0.101 | 0.068 | 0.101 | Toll-Like receptor 4 antagonist | |||
| 0.222 | 0.19 | 0.222 | 15-Lipoxygenase inhibitor | 0.221 0.19 CID_13911053 | ||
| 0.084 | 0.052 | 0.084 | Thioredoxin reductase inhibitor | |||
| 0.208 | 0.176 | 0.228 | Interleukin 2 agonist | 0.228 0.145 CID_13911053 | CID_13911053 | |
| 0.191 | 0.163 | 0.2 | Gastrin inhibitor | 0.2 0.149 CID_13911053 | CID_13911053 | |
| 0.134 | 0.107 | 0.137 | Melanin inhibitor | 0.137 0.101 CID_13911053 | CID_13911053 | |
| 0.044 | 0.017 | 0.044 | Glucose-6-phosphate dehydrogenase inhibitor | 0.043 0.017 CID_13911053 | ||
| 0.035 | 0.008 | 0.035 | 5-Alpha-reductase 2 inhibitor | 0.025 0.01 CID_13911053 | ||
| 0.029 | 0.003 | 0.029 | Progesterone receptor A antagonist | 0.014 0.004 CID_13911053 | ||
| 0.128 | 0.105 | 0.128 | Sigma receptor agonist | |||
| 0.178 | 0.156 | 0.178 | DNA synthesis inhibitor | |||
| 0.042 | 0.021 | 0.042 | Farnesoid X receptor agonist | |||
| 0.139 | 0.127 | 0.158 | Interleukin antagonist | 0.158 0.112 CID_13911053 | CID_13911053 | |
| 0.058 | 0.047 | 0.058 | Adrenaline uptake inhibitor | 0.054 0.052 CID_13911053 | ||
| 0.149 | 0.139 | 0.186 | Neurotrophic factor enhancer | 0.186 0.091 CID_13911053 | CID_13911053 | |
| 0.097 | 0.089 | 0.097 | DNA polymerase I inhibitor | |||
| 0.013 | 0.006 | 0.013 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.013 0.006 CID_13911053 | ||
| 0.007 | 0.003 | 0.007 | Transcortin receptor antagonist | 0.005 0.004 CID_13911053 | ||
| 0.015 | 0.012 | 0.015 | Antibiotic Tetracycline-like | |||
| 0.158 | 0.174 | 0.169 | Peptidyltransferase inhibitor | 0.169 0.148 CID_13911053 | CID_13911053 | |
| 0.116 | 0.145 | 0.144 | Pregnane X receptor agonist | 0.144 0.065 CID_13911053 | CID_13911053 | |
| 0.065 | 0.143 | 0.121 | Adenylate cyclase inhibitor | 0.121 0.066 CID_13911053 | CID_13911053 | |
| 0.089 | 0.663 | 0.209 | MAP kinase kinase 3 inhibitor | 0.209 0.097 CID_13911053 | CID_13911053 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |